ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 959,55
0,57%
Dow Jones
38 225,66
0,85%
DAX
17 985,54
0,45%
Brent Oil
83,865
0,28%
Bitcoin
59 010,81
-0,19%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Aeterna Zentaris Inc (AEZS)

  7. Aeterna Zentaris Inc (AEZS) Actualités

AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:AEZS
DateHeureSourceTitreSymboleSociété
14/12/202314h18PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - AEZSTSX:AEZSAeterna Zentaris Inc
14/12/202314h16PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - AEZSTSX:AEZSAeterna Zentaris Inc
14/12/202314h14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - AEZSTSX:AEZSAeterna Zentaris Inc
14/12/202314h12PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - AEZSTSX:AEZSAeterna Zentaris Inc
13/03/201912h53PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - AEZSTSX:AEZSAeterna Zentaris Inc
13/03/201912h52PR Newswire (Canada)IIROC Trade Resumption - AEZSTSX:AEZSAeterna Zentaris Inc
12/03/201920h32PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - AEZSTSX:AEZSAeterna Zentaris Inc
12/03/201920h27PR Newswire (Canada)IIROC Trading Halt - AEZSTSX:AEZSAeterna Zentaris Inc
21/12/201714h26PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - AEZS; BNETSX:AEZSAeterna Zentaris Inc
21/12/201714h23PR Newswire (Canada)IIROC Trade Resumption - AEZS; BNETSX:AEZSAeterna Zentaris Inc
03/02/201014h35PR Newswire (US)AEterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-040NASDAQ:AEZS
29/01/201014h35PR Newswire (US)AEterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of AdvancedNASDAQ:AEZS
29/01/201014h30PR Newswire (US)Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced NASDAQ:AEZS
27/01/201022h00PR Newswire (US)Keryx Biopharmaceuticals, Inc. to Conduct Conference Call to Discuss KRX-0401 (Perifosine) Clinical Development Program in ColorNASDAQ:AEZS
25/01/201014h35PR Newswire (US)AEterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, DouNASDAQ:AEZS
25/01/201014h30PR Newswire (US)Keryx Reports Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-ControllNASDAQ:AEZS
22/01/201022h05PR Newswire (US)AEterna Zentaris Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:AEZS
21/01/201014h35PR Newswire (US)AEterna Zentaris Partner, Keryx Biopharmaceuticals, to Present Poster Highlighting Clinical Activity of Perifosine (KRX-0401) atNASDAQ:AEZS
21/01/201014h30PR Newswire (US)Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the ASCO 2010 NASDAQ:AEZS
18/12/200913h15PR Newswire (US)AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and LicensinNASDAQ:AEZS
16/12/200914h35PR Newswire (US)AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients wNASDAQ:AEZS
09/12/200913h30PR Newswire (US)AEterna Zentaris Announces Appointment of New Board MemberNASDAQ:AEZS
07/12/200914h35PR Newswire (US)AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the TrNASDAQ:AEZS
07/12/200914h30PR Newswire (US)Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the TreaNASDAQ:AEZS
07/12/200913h40PR Newswire (US)AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic HyperplasiaNASDAQ:AEZS
02/12/200914h35PR Newswire (US)AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of RelapsedNASDAQ:AEZS
02/12/200914h30PR Newswire (US)Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple MyelomaNASDAQ:AEZS
24/11/200913h00PR Newswire (US)AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in EndomeNASDAQ:AEZS
11/11/200914h35PR Newswire (US)AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (NASDAQ:AEZS
11/11/200914h30PR Newswire (US)Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st AnnuaNASDAQ:AEZS
 Showing the most relevant articles for your search:TSX:AEZS

Dernières Valeurs Consultées

EU
EN
Bouygues
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
EU
ORA
Orange
EU
AI
Air Liquide
NASDAQ
AAPL
Apple
EU
RI
Pernod Ricard
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
EU
CAP
Capgemini
NYSE
NKE
Nike
EU
BN
Danone
NYSE
DIS
Walt Disney
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés